Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 3Gastrointestinal 3Other hematologic neoplasm 2Head & Neck 2Thoracic 1Sarcoma 1Myeloid 1Lymphoid 1Dermatologic 1Breast 1

Conditions

Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1

Interventions

Cyclophosphamide 49fludarabine phosphate 41fludarabine 36Azacitidine 34Busulfan 30Whole-Body Irradiation 26Antilymphocyte Serum 24Tacrolimus 23Imatinib Mesylate 23Mycophenolic Acid 22Cytarabine 20Filgrastim 19Peripheral Blood Stem Cell Transplantation 17Methotrexate 17Melphalan 17Cyclosporine 16thymoglobulin 14venetoclax 13Granulocyte Colony-Stimulating Factor 13Thiotepa 12ruxolitinib 11Stem Cell Transplantation 11Decitabine 11Dasatinib 11Alemtuzumab 11nilotinib 10Radiotherapy 10Rituximab 9Cord Blood Stem Cell Transplantation 9ponatinib 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Reverse Transcriptase Polymerase Chain Reaction × Myeloid × Clear all
NCT00428077 2011-09-02

Vaccine Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia

OHSU Knight Cancer Institute

Phase 2 Terminated
4 enrolled 7 charts
MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡